This is for a non-disease modifying drug - wonder what the price would be for a disease modifying HD drug.
Acorda Therapeutics is gambling $525 million on a Phase III-ready Parkinson's treatment
ACOR is trading up 18% right now...
Acorda Therapeutics is gambling $525 million on a Phase III-ready Parkinson's treatment, striking an all-cash deal to buy Civitas Therapeutics.
Acorda CEO Ron Cohen
Acorda ($ACOR) now has control of CVT-301, a fast-acting rescue formulation of levodopa that can be self-administered through an inhaler. Just weeks ago Civitas nailed down a $55 million venture round from a long lineup of backers, then pivoted to an IPO filing. But that was evidently all part of the bargaining process for this drug, with Acorda settling on an unusual all-cash deal for an experimental program.
and-
"Sales from CVT-301 are expected to exceed $500 million, according to Ron Cohen, Acorda's CEO. Acorda expects to complete another trial and then file for regulatory approval in the U.S. by the end of 2016."
- Forums
- ASX - By Stock
- Acorda Therapeutics is gambling $525 million on a Phase III-ready Parkinson's treatment
This is for a non-disease modifying drug - wonder what the price...
-
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $18.45K | 6.153M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
66 | 112553933 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 140078273 | 50 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
65 | 111553933 | 0.002 |
26 | 137910148 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 139953273 | 49 |
0.005 | 15696205 | 18 |
0.006 | 17812414 | 17 |
0.007 | 52406651 | 23 |
0.008 | 39320994 | 30 |
Last trade - 11.42am 18/10/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |